Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Mechanisms of palmitic acid-conjugated antisense oligonucleotide distribution in mice
Alfred E. Chappell, Hans Gaus, Andrés Berdeja, et al.
Nucleic Acids Research (2020) Vol. 48, Iss. 8, pp. 4382-4395
Open Access | Times Cited: 46

Showing 1-25 of 46 citing articles:

Expanding RNAi therapeutics to extrahepatic tissues with lipophilic conjugates
Kirk Brown, Jayaprakash K. Nair, Maja M. Janas, et al.
Nature Biotechnology (2022) Vol. 40, Iss. 10, pp. 1500-1508
Open Access | Times Cited: 162
Targeting the transferrin receptor to transport antisense oligonucleotides across the mammalian blood-brain barrier
Scarlett J. Barker, Mai B. Thayer, Chaeyoung Kim, et al.
Science Translational Medicine (2024) Vol. 16, Iss. 760
Closed Access | Times Cited: 23
Lymphatic targeting by albumin-hitchhiking: Applications and optimisation
Mohammad Abdallah, Olivia Müllertz, Ian K. Styles, et al.
Journal of Controlled Release (2020) Vol. 327, pp. 117-128
Open Access | Times Cited: 82
Overcoming the challenges of tissue delivery for oligonucleotide therapeutics
Tufan Gökirmak, Mehran Nikan, Svenja Wiechmann, et al.
Trends in Pharmacological Sciences (2021) Vol. 42, Iss. 7, pp. 588-604
Closed Access | Times Cited: 60
Deciphering albumin-directed drug delivery by imaging
Huiyu Hu, Jeremy M. Quintana, Ralph Weissleder, et al.
Advanced Drug Delivery Reviews (2022) Vol. 185, pp. 114237-114237
Open Access | Times Cited: 42
Systematic screening identifies therapeutic antisense oligonucleotides for Hutchinson–Gilford progeria syndrome
M. Puttaraju, Michaela Jackson, Stéphanie Klein, et al.
Nature Medicine (2021) Vol. 27, Iss. 3, pp. 526-535
Closed Access | Times Cited: 55
High-resolution visualization and quantification of nucleic acid–based therapeutics in cells and tissues using Nanoscale secondary ion mass spectrometry (NanoSIMS)
Cuiwen He, Michael T. Migawa, Kai Chen, et al.
Nucleic Acids Research (2020) Vol. 49, Iss. 1, pp. 1-14
Open Access | Times Cited: 53
The chemical structure and phosphorothioate content of hydrophobically modified siRNAs impact extrahepatic distribution and efficacy
Annabelle Biscans, Jillian Caiazzi, Sarah M. Davis, et al.
Nucleic Acids Research (2020) Vol. 48, Iss. 14, pp. 7665-7680
Open Access | Times Cited: 52
Docosanoic acid conjugation to siRNA enables functional and safe delivery to skeletal and cardiac muscles
Annabelle Biscans, Jillian Caiazzi, Nicholas McHugh, et al.
Molecular Therapy (2020) Vol. 29, Iss. 4, pp. 1382-1394
Open Access | Times Cited: 51
Delivery of Oligonucleotides: Efficiency with Lipid Conjugation and Clinical Outcome
Phuc Tran, Tsigereda Weldemichael, Zhichao Liu, et al.
Pharmaceutics (2022) Vol. 14, Iss. 2, pp. 342-342
Open Access | Times Cited: 30
Targeting Transferrin Receptor to Transport Antisense Oligonucleotides Across the Blood-Brain Barrier
Scarlett J. Barker, Mai B. Thayer, Chaeyoung Kim, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access | Times Cited: 17
RNAi mediated silencing of STAT3/PD-L1 in tumor-associated immune cells induces robust anti-tumor effects in immunotherapy resistant tumors
Shanthi Ganesh, Min Ju Kim, Jenny Lee, et al.
Molecular Therapy (2024) Vol. 32, Iss. 6, pp. 1895-1916
Open Access | Times Cited: 6
Directing the Way—Receptor and Chemical Targeting Strategies for Nucleic Acid Delivery
Ricarda C. Steffens, Ernst Wagner
Pharmaceutical Research (2022) Vol. 40, Iss. 1, pp. 47-76
Open Access | Times Cited: 25
Palmitic acid conjugation enhances potency of tricyclo-DNA splice switching oligonucleotides
Karima Relizani, Lucía Echevarría, Faouzi Zarrouki, et al.
Nucleic Acids Research (2021) Vol. 50, Iss. 1, pp. 17-34
Open Access | Times Cited: 28
Recent Progress and Challenges in the Development of Antisense Therapies for Myotonic Dystrophy Type 1
Thiéry De Serres‐Bérard, Siham Ait Benichou, Dominic Jauvin, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 21, pp. 13359-13359
Open Access | Times Cited: 19
Therapeutic Oligonucleotides: An Outlook on Chemical Strategies to Improve Endosomal Trafficking
Priyanka Mangla, Quentin Vicentini, Annabelle Biscans
Cells (2023) Vol. 12, Iss. 18, pp. 2253-2253
Open Access | Times Cited: 13
Lymphatic uptake of the lipidated and non-lipidated GLP-1 agonists liraglutide and exenatide is similar in rats
Sanjeevini Babu Reddiar, Mohammad Abdallah, Ian K. Styles, et al.
European Journal of Pharmaceutics and Biopharmaceutics (2024) Vol. 200, pp. 114339-114339
Open Access | Times Cited: 4
Heteroduplex oligonucleotide technology boosts oligonucleotide splice switching activity of morpholino oligomers in a Duchenne muscular dystrophy mouse model
J Hasegawa, Tetsuya Nagata, Kensuke Ihara, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 4
MTDH antisense oligonucleotides reshape the immunosuppressive tumor microenvironment to sensitize Hepatocellular Carcinoma to immune checkpoint blockade therapy
Jing-Lei Wan, Biao Wang, Mei-Lan Wu, et al.
Cancer Letters (2022) Vol. 541, pp. 215750-215750
Closed Access | Times Cited: 17
Characterizing the plasma protein binding profiles of chemistry diversified antisense oligonucleotides in human and mouse plasma using an ultrafiltration method
Cassandra Yun, Kazuki Fukami, Raku Shinkyo, et al.
Frontiers in Pharmacology (2025) Vol. 15
Open Access
Pharmacokinetics and protein binding of cholesterol-conjugated heteroduplex oligonucleotide
Yukitake Yoshioka, S. Yamamoto, Kosuke Kusamori, et al.
Journal of Controlled Release (2025) Vol. 380, pp. 787-799
Open Access
Lipid-drug conjugates: conjugation methods and therapeutic benefits
L. Ronibala Singha, Sentu Das, Malay K. Das
Elsevier eBooks (2025), pp. 29-49
Closed Access
Neonatal Fc Receptor Participates in Endocytosis of Fc Fusion Protein In Vivo and In Vitro
Yaping Zhou, Yanfang Wang, Hongmei Zhao, et al.
Veterinary Immunology and Immunopathology (2025), pp. 110930-110930
Open Access
Chemical Insights into Oligonucleotide–Protein Binding for Therapeutic Applications
Shalini Gupta, Abhishek Gupta, Mandira Mukherjee, et al.
Journal of Medicinal Chemistry (2025)
Closed Access
Distribution and biotransformation of therapeutic antisense oligonucleotides and conjugates
Lars Weidolf, Anders Björkbom, Anders Dahlén, et al.
Drug Discovery Today (2021) Vol. 26, Iss. 10, pp. 2244-2258
Closed Access | Times Cited: 23
Page 1 - Next Page

Scroll to top